Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: gcduck / Re: Will there be a 13G filing in February?

If you're saying that Lincoln had 38M shares, and Swartz had ANOTHER 38M shares, than I think you are incorrect.  I believe that they are treated as one entity for the purposes of the agreement with PTSC & the reporting of their shares.  I get that from reading the Principal Shareholders section of the proxy filing found here:

http://www.sec.gov/Archives/edgar/data/836564/000114420407016280/v069772def14a.htm

Share
New Message
Please login to post a reply